Topic: Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162

Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162 (ARRY-438162) in patients with advanced solid tumors.

http://mct.aacrjournals.org/cgi/content … B243?rss=1

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.